GENETIC REASONS OF SUDDEN CARDIAC DEATH


Cite item

Full Text

Abstract

The review presents the recent data on genetic reasons of sudden cardiac death. Mutations discuss in gens associated with sudden cardiac death. Channalopathies, such as Brugada syndrome, long QT syndrome, short QT syndrome and catecholaminergic polymorphic ventricular tachycardia are characterized by arrhythmias in normal heart resulting from genetic anomalies in ion channels

About the authors

S N Kolyubaeva

S. M. Kirov Military Medical Academy the Russian Defense Ministry

References

  1. Tester D. J., Ackerman M. J. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies channelopathies in clinical practice. Circulation. 2011; 123 (9): 1021-37. doi: 10.1161/CIRCULATIONAHA.109.914838
  2. Fernández-Falgueras A., Sarquella-Brugada G., Brugada J., Brugada R., Campuzano O. Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances. Biology. 2017; 6: 7-28. doi: 10.3390/biology6010007
  3. Lakshmanadoss U., Mertens A., Gallagher M., Kutinsky I., Williamson B. Sudden cardiac arrest due to a single sodium channel mutation producing a mixed phenotype of Brugada and Long QT3 syndromes. Indian Pacing Electrophysiol. J. 2016; 16 (2): 66-9.
  4. Turker I., Ai T., Itoh H., Horie M. Pharmacol Ther. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes. Pharmacology. Therapeutics. 2017; 176: 48-59.
  5. Patel R. B., Vaduganathan M., Shah S. J., Butler J. Atrial fibrillation in heart failure with preserved ejection fraction: Insights into mechanisms and therapeutics. Pharmacol. Ther. 2017; 176: 32-9.
  6. Ravens U., Odening K. Atrial fibrillation: Therapeutic potential of atrial K+ channel blockers. Pharmacol. Ther. 2017; 176: 13-21.
  7. Mustroph J., Neef S., Maier L. CaMKII as a target for arrhythmia suppression. Pharmacol. Ther. 2017; 176: 22-31.
  8. Liu X., Shen Y., Xie J., Bao H., Cao Q., Wan R., Xu X., Zhou H., Huang L., Xu Z., Zhu W., Hu. J., Cheng X., Hong K. A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study. 2017. 12 (5): e0177532. doi: 10.1371/journal. pone.0177532
  9. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation and sudden carnal-averaged electro- cardiоgraphy and body surface maps. J. Cardiovasc. Electrophysiоl. 2004; 8: 870-6.
  10. Watanabe H. Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J. Clin. Invest. 2016; (118); 6: 2260-8.
  11. Zaklyaz’minskaya E. V., Shestak A. Sh., Revishvili A. Sh., Pronicheva I. V., Podolyak D. G., Nechaenko M. A., Polyakov A. V., Dzemeshkevich S. L. Clinical and genetic polymorphism of Brugada syndrome caused by mutations in the SCN5A gene in the Russian group of patients. Khirurgiya. 2013; 2: 49-53
  12. Brugada P., Brugada J., Roy D. Brugada syndrome 1992-2012: 20 years of scientific excitement, and more. Eur. Heart J. 2013; 34: 3610-5.
  13. Watanabe H., Koopmann T. T., Le Scouarnec S., Yang T., Ingram C. R., Schott J. J., Demolombe S., Probst V., Anselme F., Escande D. Sodium channel beta1 subunit mutations associated with brugada syndrome J. Clin. Investig. 200; 118: 2260-8.
  14. Giudicessi J. R., Ye D., Tester D. J., Crotti L., Mugione A., Nesterenko V. V., Albertson R. M., Antzelevitch C., Schwartz P. J., Ackerman M. J. Transient outward current (Ito) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm. 2011; 8: 1024-32.
  15. Le Scouarnec S., Karakachoff M., Gourraud J. B., Lindenbaum P., Bonnaud S., Portero V., Duboscq-Bidot L. Daumy X., Simonet F., Teusan R. Testing the burden of rare variation in arrhythmia- susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome. Hum. Mol. Genet. 2015; 24: 2757-63.
  16. Lehmann M. H., Timothy K. W., Frankovich D., Fromm B. S., Keating M., Locati E. H., Taggart R. T., Towbin J. A., Moss A. J., Schwartz P. J. Age-gender influence on the rate-corrected qt interval and the qt-heart rate relation in families with genotypically characterized long QT syndrome. J. Am. Coll. Cardiol. 1997; 29: 93-9.
  17. Fukuyama M., Ohno S., Makiyama T., Horie M. Novel SCN10A variants associated with Brugada syndrome. Europace. 2016; 18: 905-11.
  18. Bokeriya L. A., Revishvili A. Sh., Pronicheva I. V. Long QT Syndrome - clinical picture, diagnostics, treatment. Annaly Aritmologii. 2005; 4: 7-17
  19. Edelmann J., Schumann S., Nastainczyk M., Husser- Bollmann D., Lessig R. Long QT syndrome mutation detection by SNaPshot technique. Int. J. Legal. Med. 2012; 6: 969-73.
  20. Zumhagen A., Veldkamp M. W., Stallmeyer B., Baartscheer A., Eckardt L., Paul M., Remme C. A., Bhuiyan Z. A., Bezzina C. R., Schulze-Bahr E. A Heterozygous Deletion Mutation in the Cardiac Sodium Channel Gene SCN5A with Loss- and Gain- of-Function Characteristics Manifests as Isolated Conduction Disease, without Signs of Brugada or Long QT Syndrome. Published online 2013 Jun 28. doi: 10.1371/journal. pone.0067963.
  21. Shadeke Y., Wulasihan M., Liu Z., Yang Y., He P. Association between the SCN5A gene H558R polymorphism and atrial fibrillation in the Uygur and Han populations of Xinjiang. Int. J. Clin. Exp. Med. 2016; 9: 11663-71.
  22. Kapplinger J. D., Tester D. J., Salisbury B. A., Carr J. L., Harris-Kerr C., Pollevick G. D., Wilde A. A., Ackerman M. J. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the familion long QT syndrome genetic test. Heart Rhythm. 2009; 6: 1297-303.
  23. Mazzanti A., O’Rourke S., Ng K., Miceli C., Borio G., Curcio A., Esposito F., Napolitano C., Priori S. G. The usual suspects in sudden cardiac death of the young: A focus on inherited arrhythmogenic diseases. Expert Rev. Cardiovasc. Ther. 2014; 12: 499-519.
  24. Gukasova I. I. The syndrome of the shortened interval (clinic, diagnostics, treatment). Annaly Arytmologii. 2005; 4: 17-23
  25. Templin С., Ghadri E., Rougier J., Baumer A., Kaplan V., Albesa M., Sticht H., Rauch A., Puleo C., Hu D., Barajas-Martinez Y., Antzelevitch C., Lüscher T., Abriel H. Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). Eur. Heart J. 2011; 32; 1077-88.
  26. Giudicessi J., Ackerman B. Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. Transl. Res. 2013; 1: 1-14. doi: 10.1016/j.trsl.2012.08.005
  27. Gaita F., Giustetto C., Bianchi F., Wolpert C., Schimpf R., Riccardi R., Grossi S., Richiardi E., Borggrefe M. Short QT syndrome: A familial cause of sudden death. Circulation. 2003; 108: 965-70.
  28. Giustetto C., Schimpf R., Mazzanti A., Scrocco C., Maury P., Anttonen O., Probst V., Blanc J. J., Sbragia P., Dalmasso P. Long-term follow-up of patients with short QT syndrome. J. Am. Coll. Cardiol. 2011; 58: 587-95.
  29. Gollob M. H., Redpath C. J., Roberts J. D. The short QT syndrome: Proposed diagnostic criteria. J. Am. Coll. Cardiol. 2011; 57: 802-12.
  30. Brugada R., Hong K., Dumaine R., Cordeiro J., Gaita F., Borggrefe M., Menendez T. M., Brugada J., Pollevick G. D., Wolpert C. Sudden death associated with short-QT syndrome linked to mutations in herg. Circulation. 2004; 109: 30-5.
  31. Lieve K. V., van der Werf C., Wilde A. A. Catecholaminergic polymorphic ventricular tachycardia. Circ. J. 2016; 80: 1285-91.
  32. Refaat M. M., Hassanieh S., Scheinman M. Catecho- laminergic polymorphic ventricular tachycardia. Card. Electrophysiol. Clin. 2016; 8: 233-7.
  33. Terentyev D., Nori A., Santoro M., Viatchenko-Karpinski S., Kubalova Z., Gyorke I., Terentyeva R., Vedamoorthyrao S., Blom N. A., Valle G. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ. Res. 2006; 98: 1151-8.
  34. Priori S. G., Napolitano C. Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels. J. Clin. Investig. 2005. 115: 2033-8.
  35. Postma A. V., Denjoy I., Kamblock J., Alders M., Lupoglazoff J. M., Vaksmann G., Dubosq-Bidot L., Sebillon P., Mannens M. M., Guicheney P. Catecholaminergic polymorphic ventricular tachycardia: Ryr2 mutations, bradycardia, and follow up of the patients. J. Med. Genet. 2005; 42: 863-70.
  36. Lahat H., Pras E., Olender T., Avidan N., Ben-Asher E., Man O., Levy-Nissenbaum E., Khoury A., Lorber A., Goldman B. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in bedouin families from israel. Am. J. Hum. Genet. 2001. 69: 1378-84.
  37. Sumitomo N. Current topics in catecholaminergic polymorphic ventricular tachycardia. J. Arrhythm. 2016; 32: 344-51.
  38. Nyegaard M., Overgaard M. T., Sondergaard M. T., Vranas M., Behr E. R., Hildebrandt L. L., Lund J., Hedley P. L., Camm A. J., Wettrell G. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am. J. Hum. Genet. 2012; 91:703-12.
  39. Roux-Buisson N., Cacheux M., Fourest-Lieuvin A., Fauconnier J., Brocard J., Denjoy I., Durand P., Guicheney P., Kyndt F., Leenhardt A., Le Marec H., Lucet V., Mabo P., Probst V., Monnier N., Ray P. F., Santoni E., Trémeaux P., Lacampagne A., Fauré J., Lunardi J., Marty I. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human. Hum. Mol. Genet. 2012; 21: 2759-67.
  40. Amin A. S., Asghari-Roodsari A., Tan H. L. Cardiac sodium channelopathies. Pflugers Arch. 2010; 460: 223-37.
  41. Chen Q., Kirsch G. E., Zhang D., Brugada R., Brugada J., Brugada P., Potenza D., Moya A., Borggrefe M., Breithardt G., Ortiz-Lopez R., Wang Z., Antzelevitch C., O’Brien R. E., Schulze-Bahr E., Keating M. T., Towbin J. A., Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation Nature.1998; 392: 293-6.
  42. Petropoulou E., Soltani M., Firoozabadi A. D., Namayandeh S. M., Crockford J., Maroofian R., Jamshidi Y. Digenic inheritance of mutations in the cardiac troponin (TNNT2) and cardiac beta myosin heavy chain (MYH7) as the cause of severe dilated cardiomyopathy. Eur. J. Med. Genet. 2017; 60: 485-8.
  43. Shan S., He X., He L., Wang M., Liu C. Coexistence of congenital left ventricular aneurysm and prominent left ventricular trabeculation in a patient with LDB3 mutation: a case report. J. Med. Case. Rep. 2017; 11 (1): 229. doi: 10.1186/s13256-017-1405-1
  44. Заклязьминская Е. В., Шестак А. Ш., Ревишвили А. Ш., Проничева И. В., Подоляк Д. Г., Нечаенко М. А., Поляков А. В., Дземешкевич С. Л. Клинико-генетический полиморфизм синдрома Бругада, обусловленного мутациями в гене SCN5A, в российской группе больных. Хирургия. 2013; 2: 49-53
  45. Бокерия Л. А., Ревишвили А. Ш., Проничева И. В. Синдром удлиненного интервала QT - клиника, диагностика, лечение. Анналы аритмологии. 2005; 4: 7-17
  46. Гукасова И. И. Синдром укороченного интервала (клиника, диагностика, лечение). Анналы аритмологии. 2005; 4: 17-23

Copyright (c) 2017 Kolyubaeva S.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies